See more : Enterprise Financial Services Corp (EFSCP) Income Statement Analysis – Financial Results
Complete financial analysis of Yifeng Pharmacy Chain Co., Ltd. (603939.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yifeng Pharmacy Chain Co., Ltd., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- CB Financial Services, Inc. (CBFV) Income Statement Analysis – Financial Results
- Strata Investment Holdings Plc (SRT.AX) Income Statement Analysis – Financial Results
- Information Planning CO., LTD. (3712.T) Income Statement Analysis – Financial Results
- The Star Entertainment Group Limited (EHGRF) Income Statement Analysis – Financial Results
- Eminent Gold Corp. (EMNT.V) Income Statement Analysis – Financial Results
Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
About Yifeng Pharmacy Chain Co., Ltd.
Yifeng Pharmacy Chain Co., Ltd. retails pharmaceutical products in China. As of March 31, 2021, it operates approximately 6,279 pharmaceutical chain stores in Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The company was founded in 2001 and is based in Changsha, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.59B | 19.89B | 15.33B | 13.14B | 10.28B | 6.91B | 4.81B | 3.73B | 2.85B | 2.23B | 1.80B | 1.54B | 1.22B |
| Cost of Revenue | 14.03B | 12.03B | 9.14B | 8.15B | 6.27B | 4.17B | 2.88B | 2.25B | 1.73B | 1.34B | 1.11B | 966.14M | 784.10M |
| Gross Profit | 8.56B | 7.86B | 6.18B | 4.99B | 4.01B | 2.75B | 1.92B | 1.48B | 1.12B | 887.00M | 697.47M | 573.33M | 440.00M |
| Gross Profit Ratio | 37.89% | 39.53% | 40.35% | 37.98% | 39.01% | 39.73% | 40.04% | 39.62% | 39.23% | 39.77% | 38.66% | 37.24% | 35.94% |
| Research & Development | 33.55M | 25.31M | 15.64M | 8.31M | 5.37M | 3.24M | 0.00 | 14.79M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 148.59M | 132.73M | 83.01M | 92.17M | 63.25M | 28.02M | 14.54M | 9.75M | 8.62M | 8.00M | 5.54M | 5.38M | 53.32M |
| Selling & Marketing | 5.49B | 4.88B | 4.06B | 3.23B | 2.68B | 1.90B | 1.29B | 1.02B | 758.46M | 577.23M | 468.06M | 403.61M | 304.32M |
| SG&A | 6.45B | 5.01B | 4.14B | 3.32B | 2.74B | 1.92B | 1.31B | 1.03B | 767.08M | 585.23M | 473.60M | 408.99M | 357.64M |
| Other Expenses | 15.25M | 797.73M | 567.47M | 450.33M | 394.67M | 2.94M | 908.73K | 9.70M | 7.17M | 6.71M | 2.15M | 1.95M | 3.28M |
| Operating Expenses | 6.50B | 5.83B | 4.73B | 3.78B | 3.14B | 2.20B | 1.52B | 1.20B | 896.88M | 699.48M | 563.56M | 480.61M | 366.15M |
| Cost & Expenses | 20.53B | 17.86B | 13.87B | 11.93B | 9.41B | 6.37B | 4.40B | 3.45B | 2.63B | 2.04B | 1.67B | 1.45B | 1.15B |
| Interest Income | 74.34M | 73.21M | 64.15M | 58.50M | 22.13M | 9.69M | 19.52M | 15.61M | 21.27M | 6.67M | 5.13M | 4.82M | 0.00 |
| Interest Expense | 160.53M | 165.21M | 168.99M | 78.54M | 45.79M | 9.71M | 0.00 | 390.00K | 8.65M | 6.47M | 0.00 | 396.50K | 0.00 |
| Depreciation & Amortization | 1.83B | 1.59B | 1.31B | 1.04B | 190.49M | 147.87M | 110.53M | 86.90M | 27.15M | 21.69M | 20.57M | 14.59M | -105.43K |
| EBITDA | 3.85B | 3.64B | 2.70B | 2.15B | 954.81M | 661.28M | 493.16M | 402.60M | 246.63M | 206.32M | 154.48M | 108.15M | 74.59M |
| EBITDA Ratio | 17.03% | 17.74% | 17.86% | 10.59% | 9.50% | 9.85% | 10.26% | 9.44% | 8.92% | 9.53% | 8.67% | 7.11% | 6.09% |
| Operating Income | 2.05B | 1.89B | 1.34B | 1.17B | 815.47M | 578.32M | 427.19M | 296.63M | 232.86M | 184.83M | 132.79M | 91.48M | 74.70M |
| Operating Income Ratio | 9.10% | 9.48% | 8.74% | 8.90% | 7.94% | 8.37% | 8.89% | 7.94% | 8.18% | 8.29% | 7.36% | 5.94% | 6.10% |
| Total Other Income/Expenses | -17.19M | -8.05M | -961.43K | 30.43M | -1.17M | 2.86M | 908.73K | 9.69M | 6.74M | 6.49M | 2.32M | 448.39K | 3.09M |
| Income Before Tax | 2.04B | 1.88B | 1.34B | 1.16B | 814.30M | 581.26M | 428.10M | 305.84M | 239.60M | 191.32M | 135.12M | 93.17M | 77.79M |
| Income Before Tax Ratio | 9.02% | 9.44% | 8.73% | 8.85% | 7.92% | 8.41% | 8.91% | 8.19% | 8.42% | 8.58% | 7.49% | 6.05% | 6.36% |
| Income Tax Expense | 456.66M | 450.29M | 347.16M | 297.06M | 205.41M | 139.70M | 110.63M | 77.92M | 61.36M | 48.91M | 34.74M | 23.63M | 20.91M |
| Net Income | 1.41B | 1.26B | 887.88M | 743.52M | 543.75M | 416.41M | 313.50M | 223.89M | 175.94M | 140.56M | 99.19M | 68.60M | 55.88M |
| Net Income Ratio | 6.25% | 6.35% | 5.79% | 5.66% | 5.29% | 6.02% | 6.52% | 6.00% | 6.18% | 6.30% | 5.50% | 4.46% | 4.56% |
| EPS | 1.40 | 1.26 | 0.89 | 0.77 | 0.57 | 0.45 | 0.34 | 0.26 | 0.22 | 0.23 | 0.16 | 0.11 | 0.09 |
| EPS Diluted | 1.17 | 1.26 | 0.89 | 0.77 | 0.57 | 0.45 | 0.34 | 0.26 | 0.22 | 0.23 | 0.16 | 0.11 | 0.09 |
| Weighted Avg Shares Out | 1.01B | 1.01B | 994.43M | 967.36M | 959.87M | 927.43M | 924.15M | 860.44M | 780.90M | 607.03M | 608.89M | 613.08M | 605.87M |
| Weighted Avg Shares Out (Dil) | 1.21B | 1.01B | 1.00B | 967.36M | 960.80M | 927.47M | 924.55M | 860.44M | 786.46M | 607.03M | 608.99M | 613.34M | 605.87M |
Source: https://incomestatements.info
Category: Stock Reports